Your browser doesn't support javascript.
loading
Durable response in platinum refractory small cell carcinoma of the ovary hypercalcemic type treated with combination pembrolizumab, oral cyclophosphamide, and bevacizumab.
Shu, Michael Kee-Ming; Moses, Elena; Korangy, Elizabeth; McGrath, John; Reyes, Henry D.
Affiliation
  • Shu MK; Minimally Invasive Gynecologic Surgery, Henry Ford Health System, Detroit, Michigan, USA mikeyshu888@gmail.com.
  • Moses E; Minimally Invasive Gynecologic Surgery, Kaleida Health, Buffalo, New York, USA.
  • Korangy E; Obstetrics and Gynecology, Henry Ford Health System, Detroit, Michigan, USA.
  • McGrath J; Pathology, Kaleida Health, Buffalo, New York, USA.
  • Reyes HD; Radiology, Great Lakes Medical Imaging LLC, Buffalo, New York, USA.
Int J Gynecol Cancer ; 34(5): 777-782, 2024 May 06.
Article in En | MEDLINE | ID: mdl-38719275
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Small Cell / Cyclophosphamide / Antibodies, Monoclonal, Humanized / Bevacizumab Limits: Female / Humans / Middle aged Language: En Journal: Int J Gynecol Cancer Journal subject: GINECOLOGIA / NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Small Cell / Cyclophosphamide / Antibodies, Monoclonal, Humanized / Bevacizumab Limits: Female / Humans / Middle aged Language: En Journal: Int J Gynecol Cancer Journal subject: GINECOLOGIA / NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido